Veerhealth Care Ltd. Secures Significant Order Worth ₹5.50 Crores
Mumbai – March 20, 2026: Veerhealth Care Limited (BSE: VEERHEALTH), the parent company of Ayuveer, announced today the receipt of a substantial order valued at ₹5.50 crores from a leading Indian Fast-Moving Consumer Goods (FMCG) company. Ayuveer specializes in Ayurvedic medicines and oral care products, emphasizing natural ingredients, quality, and affordability.The order, for the supply of face care products, is expected to be fulfilled within 45 days. This represents approximately 76% of the company’s revenue from operations in the third quarter of fiscal year 2026, which totaled ₹7.26 crores. The order’s value also accounts for roughly 20% of the projected revenue for the fiscal year 2025-26.
The FMCG company placing the order operates both domestically and internationally within the personal and household care sector and is part of a 125-year-old business group.
Looking ahead to fiscal year 2026-27, Veerhealth Care anticipates total revenues of ₹45-50 crores with a Profit After Tax (PAT) of 7-10%. Ongoing discussions regarding orders with both domestic and international buyers suggest the potential for exceeding these projections.
Veerhealth Care distinguishes itself with a rare US FDA plant clearance, a significant achievement for small-cap companies. The company specializes in the manufacture of pure vegetarian toothpaste and projects revenues of ₹100 crores with a 10% PAT within the next 24 months.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.